FRIDAY, Sept. 27, 2024 -- Omitting biopsy in patients with negative magnetic resonance imaging (MRI) results is associated with a significantly...
Vous n'êtes pas connecté
A genetic test detecting brain cancer markers in cerebrospinal fluid reduces diagnostic time and eliminates the need for invasive biopsies. Researchers
FRIDAY, Sept. 27, 2024 -- Omitting biopsy in patients with negative magnetic resonance imaging (MRI) results is associated with a significantly...
Cell-free DNA (cfDNA) is a non-invasive method for detecting fetal aneuploidies, such as Down syndrome, during pregnancy.
Cell-free DNA (cfDNA) is a non-invasive method for detecting fetal aneuploidies, such as Down syndrome, during pregnancy.
Highlights: cfDNA is a non-invasive method for detecting fetal aneuploidies during pregnancy cfDNA-based Nonin
A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting...
Researchers found that COVID-19 patients experienced widespread cognitive deficits one year post-hospitalization, associated with elevated brain...
A study from Huntsman Cancer Institute at the University of Utah (the U) and NYU Langone Perlmutter Cancer Center, USA, found that a specialised...
Cranfield University researchers have invented a low-cost origami-paper sensor for detecting biomarkers in wastewater, enabling rapid tracking of...
Researchers and doctors from UCLA Health will present 23 studies covering lung cancer, pediatric cancer, survivorship, and healthcare equity,...
September is World Leukemia Month, a time to raise awareness about leukemia, the leading blood cancer in the Philippines, surpassing lymphoma and...